Yong-Jik Lee, Hyun Soo Kim, Hong Seog Seo, Jin Oh Na, You-Na Jang, Yoon-Mi Han, Hyun-Min Kim
{"title":"刺激α 1-肾上腺素能受体通过PPARδ改善血管舒缩以外的多器官细胞功能。","authors":"Yong-Jik Lee, Hyun Soo Kim, Hong Seog Seo, Jin Oh Na, You-Na Jang, Yoon-Mi Han, Hyun-Min Kim","doi":"10.1155/2020/3785137","DOIUrl":null,"url":null,"abstract":"<p><p>Cells can shift their metabolism between glycolysis and oxidative phosphorylation to enact their cell fate program in response to external signals. Widely distributed <i>α</i> <sub>1</sub>-adrenergic receptors (ARs) are physiologically stimulated during exercise, were reported to associate with the activating energetic AMPK pathway, and are expected to have biological effects beyond their hemodynamic effects. To investigate the effects and mechanism of AR stimulation on the physiology of the whole body, various <i>in vitro</i> and <i>in vivo</i> experiments were conducted using the AR agonist midodrine, 2-amino-<i>N</i>-[2-(2,5-dimethoxyphenyl)-2-hydroxy-ethyl]-acetamide. The expression of various biomarkers involved in ATP production was estimated through Western blotting, reverse transcription polymerase chain reaction, oxygen consumption rate, enzyme-linked immunosorbent assay (ELISA), fluorescence staining, and Oil red O staining in several cell lines (skeletal muscle, cardiac muscle, liver, macrophage, vascular endothelial, and adipose cells). In spontaneously hypertensive rats, blood pressure, blood analysis, organ-specific biomarkers, and general biomolecules related to ATP production were measured with Western blot analysis, immunohistochemistry, ELISA, and echocardiography. Pharmacological activation of <i>α</i> <sub>1</sub>-adrenergic receptors in C2C12 skeletal muscle cells promoted mitochondrial oxidative phosphorylation and ATP production by increasing the expression of catabolic molecules, including PPAR<i>δ</i>, AMPK, and PGC-1<i>α</i>, through cytosolic calcium signaling and increased GLUT4 expression, as seen in exercise. It also activated those energetic molecules and mitochondrial oxidative phosphorylation with cardiomyocytes, endothelial cells, adipocytes, macrophages, and hepatic cells and affected their relevant cell-specific biological functions. All of those effects occurred around 3 h (and peaked 6 h) after midodrine treatment. In spontaneously hypertensive rats, <i>α</i> <sub>1</sub>-adrenergic receptor stimulation affected mitochondrial oxidative phosphorylation and ATP production by activating PPAR<i>δ</i>, AMPK, and PGC-1<i>α</i> and the relevant biologic functions of multiple organs, suggesting organ crosstalk. The treatment lowered blood pressure, fat and body weight, cholesterol levels, and inflammatory activity; increased ATP content and insulin sensitivity in skeletal muscles; and increased cardiac contractile function without exercise training. These results suggest that the activation of <i>α</i> <sub>1</sub>-adrenergic receptor stimulates energetic reprogramming via PPAR<i>δ</i> that increases mitochondrial oxidative phosphorylation and has healthy and organ-specific biological effects in multiple organs, including skeletal muscle, beyond its vasomotion effect. In addition, the action mechanism of <i>α</i> <sub>1</sub>-adrenergic receptor may be mainly exerted via PPAR<i>δ</i>.</p>","PeriodicalId":20439,"journal":{"name":"PPAR Research","volume":"2020 ","pages":"3785137"},"PeriodicalIF":3.5000,"publicationDate":"2020-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/3785137","citationCount":"10","resultStr":"{\"title\":\"Stimulation of Alpha<sub>1</sub>-Adrenergic Receptor Ameliorates Cellular Functions of Multiorgans beyond Vasomotion through PPAR<i>δ</i>.\",\"authors\":\"Yong-Jik Lee, Hyun Soo Kim, Hong Seog Seo, Jin Oh Na, You-Na Jang, Yoon-Mi Han, Hyun-Min Kim\",\"doi\":\"10.1155/2020/3785137\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Cells can shift their metabolism between glycolysis and oxidative phosphorylation to enact their cell fate program in response to external signals. Widely distributed <i>α</i> <sub>1</sub>-adrenergic receptors (ARs) are physiologically stimulated during exercise, were reported to associate with the activating energetic AMPK pathway, and are expected to have biological effects beyond their hemodynamic effects. To investigate the effects and mechanism of AR stimulation on the physiology of the whole body, various <i>in vitro</i> and <i>in vivo</i> experiments were conducted using the AR agonist midodrine, 2-amino-<i>N</i>-[2-(2,5-dimethoxyphenyl)-2-hydroxy-ethyl]-acetamide. The expression of various biomarkers involved in ATP production was estimated through Western blotting, reverse transcription polymerase chain reaction, oxygen consumption rate, enzyme-linked immunosorbent assay (ELISA), fluorescence staining, and Oil red O staining in several cell lines (skeletal muscle, cardiac muscle, liver, macrophage, vascular endothelial, and adipose cells). In spontaneously hypertensive rats, blood pressure, blood analysis, organ-specific biomarkers, and general biomolecules related to ATP production were measured with Western blot analysis, immunohistochemistry, ELISA, and echocardiography. Pharmacological activation of <i>α</i> <sub>1</sub>-adrenergic receptors in C2C12 skeletal muscle cells promoted mitochondrial oxidative phosphorylation and ATP production by increasing the expression of catabolic molecules, including PPAR<i>δ</i>, AMPK, and PGC-1<i>α</i>, through cytosolic calcium signaling and increased GLUT4 expression, as seen in exercise. It also activated those energetic molecules and mitochondrial oxidative phosphorylation with cardiomyocytes, endothelial cells, adipocytes, macrophages, and hepatic cells and affected their relevant cell-specific biological functions. All of those effects occurred around 3 h (and peaked 6 h) after midodrine treatment. In spontaneously hypertensive rats, <i>α</i> <sub>1</sub>-adrenergic receptor stimulation affected mitochondrial oxidative phosphorylation and ATP production by activating PPAR<i>δ</i>, AMPK, and PGC-1<i>α</i> and the relevant biologic functions of multiple organs, suggesting organ crosstalk. The treatment lowered blood pressure, fat and body weight, cholesterol levels, and inflammatory activity; increased ATP content and insulin sensitivity in skeletal muscles; and increased cardiac contractile function without exercise training. These results suggest that the activation of <i>α</i> <sub>1</sub>-adrenergic receptor stimulates energetic reprogramming via PPAR<i>δ</i> that increases mitochondrial oxidative phosphorylation and has healthy and organ-specific biological effects in multiple organs, including skeletal muscle, beyond its vasomotion effect. In addition, the action mechanism of <i>α</i> <sub>1</sub>-adrenergic receptor may be mainly exerted via PPAR<i>δ</i>.</p>\",\"PeriodicalId\":20439,\"journal\":{\"name\":\"PPAR Research\",\"volume\":\"2020 \",\"pages\":\"3785137\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2020-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1155/2020/3785137\",\"citationCount\":\"10\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"PPAR Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1155/2020/3785137\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"PPAR Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2020/3785137","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 10
摘要
细胞可以在糖酵解和氧化磷酸化之间转换代谢,以响应外部信号来制定细胞命运程序。广泛分布的α 1-肾上腺素能受体(ARs)在运动过程中受到生理刺激,据报道,它与激活能量充沛的AMPK通路有关,并且有望具有超越其血流动力学作用的生物学效应。为了研究AR刺激对全身生理的影响及其机制,我们使用AR激动剂米多宁、2-氨基- n -[2-(2,5-二甲氧基苯基)-2-羟基-乙基]-乙酰胺进行了各种体外和体内实验。在几种细胞系(骨骼肌、心肌、肝脏、巨噬细胞、血管内皮细胞和脂肪细胞)中,通过Western blotting、逆转录聚合酶链反应、耗氧率、酶联免疫吸附试验(ELISA)、荧光染色和油红O染色来估计参与ATP产生的各种生物标志物的表达。在自发性高血压大鼠中,采用Western blot分析、免疫组织化学、ELISA和超声心动图测量血压、血液分析、器官特异性生物标志物和与ATP产生相关的一般生物分子。C2C12骨骼肌细胞中α 1-肾上腺素能受体的药理激活通过胞质钙信号传导增加分解代谢分子(包括PPARδ、AMPK和PGC-1α)的表达,增加GLUT4的表达,从而促进线粒体氧化磷酸化和ATP的产生,如在运动中所见。它还激活了心肌细胞、内皮细胞、脂肪细胞、巨噬细胞和肝细胞的高能分子和线粒体氧化磷酸化,并影响了它们的相关细胞特异性生物学功能。所有这些效应都发生在米多定治疗后3小时左右(6小时达到峰值)。在自发性高血压大鼠中,α 1-肾上腺素能受体刺激通过激活PPARδ、AMPK和PGC-1α,影响线粒体氧化磷酸化和ATP的产生以及多个器官的相关生物学功能,提示器官串扰。治疗降低了血压、脂肪和体重、胆固醇水平和炎症活动;骨骼肌ATP含量和胰岛素敏感性增加;在没有运动训练的情况下增加心脏收缩功能。这些结果表明,α 1-肾上腺素能受体的激活通过PPARδ刺激能量重编程,增加线粒体氧化磷酸化,并在包括骨骼肌在内的多个器官中具有健康和器官特异性的生物学效应,而不仅仅是其血管舒缩效应。此外,α 1-肾上腺素能受体的作用机制可能主要通过PPARδ发挥作用。
Stimulation of Alpha1-Adrenergic Receptor Ameliorates Cellular Functions of Multiorgans beyond Vasomotion through PPARδ.
Cells can shift their metabolism between glycolysis and oxidative phosphorylation to enact their cell fate program in response to external signals. Widely distributed α1-adrenergic receptors (ARs) are physiologically stimulated during exercise, were reported to associate with the activating energetic AMPK pathway, and are expected to have biological effects beyond their hemodynamic effects. To investigate the effects and mechanism of AR stimulation on the physiology of the whole body, various in vitro and in vivo experiments were conducted using the AR agonist midodrine, 2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxy-ethyl]-acetamide. The expression of various biomarkers involved in ATP production was estimated through Western blotting, reverse transcription polymerase chain reaction, oxygen consumption rate, enzyme-linked immunosorbent assay (ELISA), fluorescence staining, and Oil red O staining in several cell lines (skeletal muscle, cardiac muscle, liver, macrophage, vascular endothelial, and adipose cells). In spontaneously hypertensive rats, blood pressure, blood analysis, organ-specific biomarkers, and general biomolecules related to ATP production were measured with Western blot analysis, immunohistochemistry, ELISA, and echocardiography. Pharmacological activation of α1-adrenergic receptors in C2C12 skeletal muscle cells promoted mitochondrial oxidative phosphorylation and ATP production by increasing the expression of catabolic molecules, including PPARδ, AMPK, and PGC-1α, through cytosolic calcium signaling and increased GLUT4 expression, as seen in exercise. It also activated those energetic molecules and mitochondrial oxidative phosphorylation with cardiomyocytes, endothelial cells, adipocytes, macrophages, and hepatic cells and affected their relevant cell-specific biological functions. All of those effects occurred around 3 h (and peaked 6 h) after midodrine treatment. In spontaneously hypertensive rats, α1-adrenergic receptor stimulation affected mitochondrial oxidative phosphorylation and ATP production by activating PPARδ, AMPK, and PGC-1α and the relevant biologic functions of multiple organs, suggesting organ crosstalk. The treatment lowered blood pressure, fat and body weight, cholesterol levels, and inflammatory activity; increased ATP content and insulin sensitivity in skeletal muscles; and increased cardiac contractile function without exercise training. These results suggest that the activation of α1-adrenergic receptor stimulates energetic reprogramming via PPARδ that increases mitochondrial oxidative phosphorylation and has healthy and organ-specific biological effects in multiple organs, including skeletal muscle, beyond its vasomotion effect. In addition, the action mechanism of α1-adrenergic receptor may be mainly exerted via PPARδ.
期刊介绍:
PPAR Research is a peer-reviewed, Open Access journal that publishes original research and review articles on advances in basic research focusing on mechanisms involved in the activation of peroxisome proliferator-activated receptors (PPARs), as well as their role in the regulation of cellular differentiation, development, energy homeostasis and metabolic function. The journal also welcomes preclinical and clinical trials of drugs that can modulate PPAR activity, with a view to treating chronic diseases and disorders such as dyslipidemia, diabetes, adipocyte differentiation, inflammation, cancer, lung diseases, neurodegenerative disorders, and obesity.